Is there a path beyond BOLD? Molecular imaging of brain function

NeuroImage

Volumn 62, Issue 2, 2012, Pages 1208-1215

  Koretsky, Alan P ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Manganese enhanced MRI; MRI calcium indicators; MRI detection of membrane potential; MRI detection of neurotransmitters; MRI gene expression reporters

Indexed keywords

4 AMINOBUTYRIC ACID; BETA GALACTOSIDASE; CALCIUM ION; DOPAMINE; FERRITIN; GADOLINIUM; GLUTAMIC ACID; MANGANESE;

BIOACCUMULATION; BOLD SIGNAL; BRAIN CELL; BRAIN FUNCTION; BRAIN REGION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTRAST ENHANCEMENT; GENE EXPRESSION; HUMAN; IMAGE ANALYSIS; MOLECULAR IMAGING; NERVE CELL MEMBRANE POTENTIAL; NEUROIMAGING; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SIGNAL DETECTION; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN MAPPING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84862981204     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.02.076     Document Type: Review

References (139)

1. Ackerman J.J., Ewy C.S., Kim S.G., Shalwitz R.A. Deuterium magnetic resonance in vivo: the measurement of blood flow and tissue perfusion. Ann. NY. Acad. Sci. 1987, 508:89-98.
2. Angelovski G., Fuskova P., Mamedov I., Canals S., Toth E., Logothetis N.K. Smart Magnetic Resonance Imaging Agents that sense extracellular calcium fluctuations. ChemBioChem 2008, 9:1729-1734.
3. Angelovski G., Chauvin T., Pohmann R., Logothetis N.K., Toth E. Caclium responsive paramagnetic CEST agents. Biorg. Med. Chem. 2011, 19:1097-1105.
4. Aoki I., Wu Y.J., Silva A.C., Lynch R.M., Koretsky A.P. In vivo detection of neuroarchitecture in the rodent brain using manganese enhanced MRI. NeuroImage 2004, 22:1046-1059.
5. Arai T., Nakao S., Mori K., Ishimori K., Morishima I., Miyazawa T., Fritz-Zieroth B. Cerebral oxygen utilization analyzed by the use of oxygen-17 and its nuclear magnetic resonance. Biochem. Biophys. Res. Commun. 1990, 169:153-158.
6. Arena F., Singh J.B., Gianolio E., Stefania R., Aime S. b-Gal gene expression MRI reporter in melanoma tumor cells. Design, synthesis, and in vitro and in vivo testing gof a Gd(III) containing probe forming a high relaxivity, melanin-like structure upon b-Gal enzymatic activation. Bioconjug. Chem. 2011, 22:2625-2635.
7. Atanasijevic T., Shusteff M., Fam P., Jasanoff A. Caclium sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin. Proc. Natl. Acad. Sci. 2006, 103:14707-14712.
8. Aung W., Hasegawa S., Koshikawa-Yana M., Obata T., Ikehira H., Furukawa T., Aoki I., Saga T. Visualizaton of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging. Gene Ther. 2009, 16:830-839.
9. Auricchio A., Zhou R., Wilson J.M., Glickson J.D. In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene. Proc. Natl. Acad. Sci USA 2001, 98:5205-5210.
10. Bador-Goffer R.S., Ben-Yoseph O., Dolin S.J., Morris P.G., Smith G.A., Bachelard H.S. Use of 1,2-bis(2-amino-5-fluorophenoxy)ethane-N, N, N', N'-tetraacetic acid (5FBAPTA) in the measurement of free intracellular calcium in the brain b y 19F-nuclear magnetic resonance spectroscopy. J. Neurochem. 1990, 55:878-884.
11. Bandettini P.A., Petridou N., Bodurka J. Direct detection of neuronal activity with MRI: fantasy, possibility, or reality?. Appl. Magn. Reson. 2005, 29:65-75.
12. Barth A. Visulaizing circuits and systems using transgenic reporters of neural activity. Curr. Opin. Neurobiol. 2007, 17(567):571.
13. Bengtsson N.E., Brown G., Scott E.W., Walter G.A. lacZ as a genetic reporter for real time MRI. Magn. Reson. Med. 2010, 63:745-753.
14. Bennett K.M., Shapiro E.M., Sotak C.H., Koretsky A.P. Controlled aggregation of ferritin to modulate MRI relaxivity. Biophys. J. 2008, 95:342-351.
15. Berkowitz B.A., Roberts R., Goebel D.J., Luan H. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest. Ophthalmol Vis Sci. 2006, 47:2668-2674.
16. Berkowitz B.A., Roberts R., Oleske D.A., Chang M., Schafer S., Bissig D., Gradianu M. Quantitative mapping of ion channel regulation by visual cycle activity in rodent photoreceptors in vivo. Invest. Ophthalmol. Vis. Sci. 2009, 50:1880-1885.
17. Bock N.A., Kocharyan A., Silva A.C. Manganese enhanced MRI visualizes V1 in the non-human primate visual cortex. NMR Biomed. 2009, 22:730-736.
18. Boretius S., Frahm J. Manganese-enhanced magnetic resonance imaging. Methods Mol. Biol. 2011, 771:531-568.
19. Brindle K., Braddock P., Fulton S. 31P NMR measurements of the ADP concentration in yeast cells genetically modified to express creatine kinase. Biochemistry 1990, 29:3295-3302.
20. Bulte J.W. In vivo MRI cell tracking: clinical studies. AJR Am. J. Roentgenol. 2009, 193:314-325.
21. Chang Y.T., Cheng C.M., Su Y.Z., Lee W.T., Hsu J.S., Liu G.C., Cheng T.L., Wang Y.M. Synthesis and characterization of a new bioactivated paramagnetic gadolinium(III) complex [Gd(DOTA-FPG(H2O)] for tracing gene expression. Bioconjug Chem. 2007, 18:1716-1727.
22. Chavane F., Sharon D., Jancke D., Marre O., Fregnac Y., Grinvald A. Lateral spread of orientation selectivity in V1 is controlled by intracortical cooperativity. Front. Syst. Neurosci. 2011, 5:4. E pub ahead of print.
23. Chen Z.G., Silva A.C., Yang J.H., Shen J. Elevated endogenous GABA levels correlates with decreased fMRI signals in the rat brain during acute inhibition of GABA transaminase. J. Neurosci. Res. 2005, 79:383-391.
24. Choi S.H., Cho H.R., Kim H.S., Kim Y.H., Kang K.W., Kim H., Moon W.K. Imaging and quantification of metastatic melanoma cells in lymph modes with a ferritin MR reporter in living mice. NMR Biomed. 2012, 25:737-745.
25. Chuang K.H., Lee J.H., Silva A.C., Belluscio L., Koretsky A.P. Manganese enhanced MRI reveals functional circuitry in response to odorant stimuli. NeuroImage 2009, 44:363-372.
26. Chuang K.H., Koretsky A.P., Sotak C.H. Temporal changes in the T1 and T2 relaxation rates (Delta R1 and Delta R2) in the rat brain are consistent with the tissue-clearance rates of elemental manganese. Magn. Reson. Med. 2009, 61:1528-1532.
27. Chuang K.H., Belluscio L., Koretsky A.P. In vivo detection of individual glomeruli in the rodent olfactory bulb using manganese enhanced MRI. NeuroImage 2010, 49:1350-1356.
28. Clark L.C., Ackerman J.L., Thomas S.R., Millard R.W., Hoffman R.E., Pratt R.G., Ragle-Cole H., Kinsey R.A., Janakiraman R. Perfluorinated organic liquids and emulsions as biocompatible NMR imaging agents for 19F and dissolved oxygen. Adv Exp Med Biol 1984, 180:835-845.
29. Cohen B., Dafni H., Meir G., Harmelin A., Neeman M. Ferritin as an Endogenous MRI Reporter for Noninvasive Imaging of Gene Expression in C6 Glioma Tumors 2005, 7, 109-117.
30. Cohen B., Ziv K., Plaks V., Israely T., Kalchenko V., Harmelin A., Benjamin L.E., Neeman M. MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat. Med. 2007, 13:498-503.
31. Colomb J., Louie K., Massia S.P., Bennett K.M. Self-degrading, MRI detectable hydrogel sensors with picomolar target sensitivity. Magn. Reson. Med. 2011, 64:1792-1799.
32. Cui W., Otten P., Li Y., Koeneman K.S., Yu J., Mason R.P. Novel NMR approach to assessing gene transfection:4-fluoro-2-nitrophenyl-beta-d-galactopyranoside as a prototype reporter molecule for beta-galactosidase. Magn. Reson. Med. 2004, 51:616-620.
33. Cui W., Liu L., Kodibagker V.D., Mason R.P. S-Gal, a novel 1H MRI reporter for beta-galactosidase. Magn. Reson. Med. 2010, 64:65-71.
34. Deans A.E., Wadghiri Y.Z., Bernas L.M., Yu X., Rutt B.K., Turnball D.H. Cellular MRi contrast via co-expression of transferrin receptor and ferritin. Magn. Reson. Med. 2006, 56:51-59.
35. Deuel R.K., Yue G.M., Sherman W.R., Schickner D.J., Ackerman J.J. Science 1985, 228:1329-1330.
36. Eschenko O., Canals S., Simanova I., Logothetis N. Behavioral, electrophysiological and histopathological consequences of systemic manganese administration in MEMRI. Magn Reson Imaging 2010, 28:1165-1174.
37. Eschenko O., Canals S., Simanova I., Beyerlein M., Murayama Y., Logothetis N.K. Mapping of functional brain activity in freely behaving rats during voluntary running using manganese-enhanced MRI: implications for longitudinal studies. NeuroImage 2010, 49:2544-2555.
38. Esqueda A.C., Lopez J.A., Andreu-de-Riquer G., Alvarado-Monzon J.C., Ratnakar J., Lubag A.J., Sherry A.D., De leon-Rodriquez L.M. A new gadolinium-based zinc sensor. J. Am. Chem. Soc. 2009, 131:11387-11391.
39. 2+ Influx in hippocampal CA1 pyramidal neurons via extracellular carbonic anhydrase. J. Neurosci. 2007, 27:1167-1175.
40. Frank S., Lauterbur P.C. Voltage sensitive magnetic gels as magnetic resonance monitoring agents. Nature 1993, 363:334-336.
41. Genove G., DeMarco U., Xu H., Goins W.F., Ahrens E.T. A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 2005, 11:450-454.
42. Gilad A.A., McMahon M.T., Walczak P., Winnard P.T., Raman V., van Laarhoven H.W., Skoglund C.N., Bulte J.W., van Zijl P.C. Artificial reporter gene providing MRI contrast based on proton exchange. Nat. Biotechnol. 2007, 25:217-219.
43. Gilad A.A., Winnard P.T., van Zijl P.C., Bulte J.W. Developing MR reporter genes: promised and pitfalls. NMR Biomed. 2007, 20:275-290.
44. Goldhawk D.E., Lemaire C., McCreary C.R., McGirr R., Dhanvantari S., Thompson R.T., Figueredo R., Koropatnick J., Foster P., Prato F.S. Magnetic resonance imaging of cells overexpressing MagA, an endogenous contrast agent for live cell imaging. Mol. Imaging 2009, 8:129-139.
45. Granot D., Shapiro E.M. Release activation of iron oxide nanoparticles: (REACTION) a novel environmentally sensitive MRI paradigm. Magn. Reson. Med. 2011, 65:1253-1259.
46. Green D.F., Dennis A.T., Fam P.S., Tidor B., Jasanoff A. Rational design of new binding specificity by simultaneous mutagenesis of calmodulin and a target peptide. Biochemistry 2006, 45:12547-12559.
47. Hanaoka K., Kikuchi K., Terai T., Kmatsu T., Nagano T. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon. Chemistry 2008, 14:987-995.
48. Hasegawa S., Saito S., Takanashi J., Morokoshi Y., Furukawa T., Saga T., Aoki I. Evaluation of ferritin-overexpressing brain in newly developed transgenic mice. Magn Reson Imaging 2011, 29:179-184.
49. Haun J.B., Yoon T.J., Lee H., Weissleder R. Molecular detection of biomarkers and cells using magnetic nanoparticles and diagnostic magnetic resonance. Methods Mol. Biol. 2011, 726:33-49.
50. Hawrylak N., Ghosh P., Broadus J., Schlueter C., Greenough W.T., Lauterbur P.C. Nuclear magnetic resonance (NMR) imaging of iron oxide labeled neural transplants. Exp. Neurol. 1993, 121:181-192.
51. Hennig J., Mamedov I., Fouskova P., Toth E., Logothetis N.K., Angelovski G., Mayer H.A. Influence of calcium induced aggregation on the sensitivity of aminobis (methylenephosphonate)-containing potential MRI contrast agents. Inorg. Chem. 2011, 50:6472-6481.
52. Ho C., Hitchens K. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ. Curr. Pharm. Biotechnol. 2004, 5:551-566.
53. Howles G.P., Qi Y., Johnson G.A. Ultrasonic disruption of the blood brain barrier enables in vivo functional mapping of the mouse barrel field cortex with manganese-enhanced MRI. NeuroImage 2010, 50:1464-1471.
54. Inoue T., Majid T., Pautler R.G. Manganese enhanced MRI (MEMRI): neurophysiological applications. Rev. Neurosci. 2011, Epub ahead of print.
55. Iordanova B., Ehrens E.T. In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. NeuroImage 2012, 59:1004-1012.
56. Iordanova B., Robison C.S., Ahrens E.T. Design and characterization of a chimeric ferritin with enhanced iron loading and transverse magnetic relaxation rate. J. Biol. Inorg. Chem. 2010, 15:957-965.
57. Jackson S.J., Hussey R., Jansen M.A., Merrifield G.D., Marshall I., MacLullich A., Yau J.L., Bast T. Manganese-enhanced magnetic resonance imaging (MEMRI) of rat brain after systemic administration of MnCl2: hippocampal signal enhancement without disruption of hippocampus-dependent behavior. Behav. Brain Res. 2011, 216:293-300.
58. Keliris A., Ziegler T., Mishra R., Pohmann R., Sauer M.G., Ugurbil K., Engelmann J. Synthesis and characterization of a cell-permeable bimodal contrast agent targeting b-galactosidase. Bioorg. Med. Chem. 2011, 19:2529-2540.
59. Kim H.S., Cho H.R., Choi S.H., Woo J.S., Moon W.K. In vivo imaging of tumor transduced with bimodal lentiviral vector encoding human ferritin and green fluorescent protein on a 1.5T clinical magnetic resonance scanner. Cancer Res. 2010, 70:7315-7324.
60. Koretsky A.P. Investigation of cell physiology in the animal using transgenic technology. Am. J. Physiol. 1995, 262:C261-C275.
61. Koretsky A.P., Traxler B.A. The B isozyme of creatine kinase is active as a fusion protein in Escherichia coli: in vivo detection by 31P NMR. FEBS Lett. 1989, 243:8-12.
62. Koretsky A.P., Brosnan M.J., Chen L.H., Chen J.D., Van Dyke T. NMR detection of the expression of creatine kinase in the liver of transgenic mice: determination of free ADP levels. Proc. Natl. Acad. Sci. USA 1990, 87:3112-3116.
63. Koretsky A.P., Lin Y.-J., Schorle H., Jaenisch Genetic control of MRI contrast by expression of the transferring receptor. Proceedings of the International Society of Magn Reson Med. 1996, 4:69.
64. Kralj J.M., Hochbaum D.R., Douglass A.D., Cohen A.E. Electrical spiking in E. coli probed with a fluorescent voltage-indicating protein. Science 2011, 333:345-348.
65. Kubicek V., Vitha T., Kotek J., Hermann P., Vander Elst L., Muller R.N., Lukes I., Peters J.A. Towards MRI contrast agents responsive to Ca(II) and Mg (II) ions: metal induced oligomerization of dota-bisphosphonate conjugates. Contrast Media Mol. Imaging 2010, 5:294-296.
66. Kuo Y.T., Herlithy A.H., So P.W., Bell J.D. Manganese-enhanced magnetic resonance imaging (MEMRI) without compromise of the blood-brain barrier detects hypothalamic neuronal activity in vivo. NMR Biomed. 2006, 19:1028-1034.
67. Landis C.S., Yamanouchi K., Zhou H., Mohan S., Roy-Chowdhury N., Shafritz D.A., Koretsky A.P., Roy-Chowdhury J., Hetherington H.P., Guha C. Noninvasive evaluation of liver repopulation by transplanted hepatocytes using 31P MRS imaging in mice. Hepatology 2006, 44:1250-1258.
68. Lauterbur P. Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 1973, 242:190-191.
69. Le Bihan D. The "wet mind": water and functional neuroimaging. Phys. Med. Biol. 2007, 52:R57-R90.
70. Lee T., Zhang X.A., Dhar S., Faas H., Lippard S.J., Jasanoff A. In vivo imaging with a cell permeable porphyrin-based MRI contrast agent. Chem. Biol. 2010, 17:665-673.
71. Lelyveld V.S., Brustad E., Arnold F.H., Jasanoff A. Metal-substituted protein MRI contrast agents engineered for enhanced relaxivity and ligand sensitivity. J. Am. Chem. Soc. 2011, 133:649-651.
72. Li W.H., Fraser S.E., Meade T.J. J. Am. Chem. Soc. 1999, 121:1413-1414.
73. Li W.H., Parigi G., Fragai M., Luchinat C., Meade T.J. Mechanistic studies of a calcium dependent MRI contrast agent. Inorg. Chem. 2002, 41:4018-4024.
74. Li Z., Qiao H., Lebherz C., Choi S.R., Zhou X., Gao G., Kung H.F., rader D.J., Wilson J.M., Glickson J.D., Zhou R. Creatine kinase a magnetic resonance-detectable marker gene for quantification of liver-directed gene transfer. Hum Gene Ther. 2005, 16:1429-1438.
75. Lin Y.J., Koretsky A.P. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn. Reson. Med. 1997, 38:378-388.
76. Liu S. Ether and crown ether-containing cationic 99mTc complexes useful as radiopharmaceuticals for heart imaging. Dalton Trans. 2007, 12:1183-1193.
77. Liu L., Kodibagakar V.D., Yu J.X., Mason R.P. 19F-NMR detection of lacZ gene expression via the enzymatic hydrolysis of 2-fluoro-4 nitrophenyl beta d-galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse. FASEB J. 2007, 21:2014-2019.
78. Liu C.H., Ren J.Q., Yang J., Liu C.M., Mandeville J.B., Bhide P.G., Yanagawa Y., Liu P.K. DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains. J. Neurosci. 2009, 29:10662-10670.
79. Liu G., Bulte J.W., Gilad A.A. CEST MRI reporter genes. Methods Mol Biol. 2011, 711:271-280.
80. Liu C.H., Ren J.Q., You Z., Yang J., Liu C.M., Uppal R., Liu P.K. Noninvasive detection of neural progenitors cells in living brains by MRI. FASEB J. 2012, 26:1652-1662.
81. Looger L.L., Griesbeck O. Genetically encoded neural activity indicators. Curr. Opin. Neurobiol. 2012, 22:18-23.
82. Louie A.Y., Huber M.M., Ahrens E.T., Rothbacher U., Moats R., Jacobs R.E., Fraser S.E., Meade T.J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotech. 2000, 18:321-325.
83. Lu H., Denny S., Zuo Y., Rea W., Wang L., Chefer S.I., Vaupel D.B., Yang Y., Stein E.A. Temporary disruption of the rat blood-brain barrier with a monoclonal antibody: a novel method for dynamic manganese-enhanced MRI. NeuroImage 2010, 50:7-14.
84. Lubag A.J., De Leon-Rodriguez L.M., Burgess S.C., Sherry A.D. Noninvasive MRI of b-cell function using a Zn2+- responsive agent. Proc. Natl. Acad. Sci. 2011, 108:18400-18405.
85. Madar I., Ravert H.T., Hilton J., Volokh L., Dannals R.F., Frost J.J., Hare J.M. Characterization and uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J. Nucl. Med. 2006, 47:1359-1366.
86. Major J.L., Parigi G., Luchinat C., Meade T.J. The synthesis and in vitro testing of a zinc-activated MRI contrast agent. Proc. Natl. Acad. Sci. 2007, 104:13881-13886.
87. Mamedov I., Logothetis N.K., Angelovski G. Structure related variable responses of calcium sensitive MRI probes. Org. Biomol. Chem. 2011, 9:5816-5824.
88. Matsumoto Y., Jasanoff A. T2 relaxation induced by clusters of superparamagnetic nanoparticles: Monte Carlo simulations. Magn Reson Imaging 2008, 26:994-998.
89. Mendoca Dias M.H., Lauterbur P.C. Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn. Reson. Med. 1986, 3:328-330.
90. Mishra A., Logothetis N.K., Parker D. Critical in vitro evaluation of responsive MRI contrast agents for calcium and zinc. Chemistry 2011, 17:1529-1537.
91. Miyawaki A., Llopis J., Heim R., McCaffery J.M., Adams J.A., Ikura M., Tsien R.Y. Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. Nature 1997, 388:882-887.
92. Moore A., Basilion J.P., Chiocca E.A., Weissleder R. Measuring transferring receptor gene expression by NMR imaging. Biochim. Biophys. 1998, 1402:239-249.
93. Moseley M.E., Cohen Y., Mintorovich J., Chileuitt L., Shimizu H., Kucharczyk J., Wendland M.F., Weinstein P.R. Early detection of regional ischemia in cats: comparison of diffusion-and T2-weighted MRI and spectroscopy. Magn. Reson. Med. 1990, 14:330-346.
94. Moseley M.E., Cohen Y., Kucharczyk J., Mintorovitch J., Asgari H.S., Wendland M.F., Tsuruda J., Norman D. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990, 176:439-445.
95. Muthukumaraswamy S.D., Edden R.A.E., Jones D.K., Swettenhan J.B., Singh K.D. Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc. Natl. Acad. Sci. USA 2009, 106:8356-8361.
96. Nauen D.W. Methods of measuring activity at individual synapses: a review of techniques and the findings they have made possible. J. Neurosci Methods 2011, 194:195-205.
97. Novotny E.J., Fulbright R.K., Pearl P.L., Gibson K.M., Rothman D.L. Magnetic resonance spectroscopy of neurotransmitters in human brain. Ann. Neurol. 2003, 54(Suppl. 6):S25-S31.
98. Ogawa S., Lee T.M. Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn. Reson. Med. 1990, 16:9-18.
99. Ogawa S., Lee T.M., Kay A.R., Tank D.W. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci USA 1990, 87:9868-9872.
100. Ogawa S., Lee T.M., Nayak A., Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn. Reson. Med. 1990, 14:68-78.
101. Ono K., Fuma K., Tabata K., Sawada M. Ferritin reporter used for gene expression imaging by magnetic resonance. Biochem. Biophys. Res. Comm. 2009, 338:589-594.
102. Parkinson J.R., Chaudhri, Bell J.D. Imaging appetite-regulating pathways in the central nervous system using manganese-enhanced magnetic resonance imaging. Neuoroendocrinology 2009, 89:121-130.
103. Pautler R.G., Silva A.C., Koretsky A.P. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 1998, 40:740-748.
104. Perez J.M., O'Loughin T., Simeone F.J., Weissleder R., Josephson L. DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. J. Am. Chem. Soc. 2002, 124:2856-2857.
105. Peterka D.S., Takahashi H., Yuste R. Imaging voltage in neurons. Neuron 2011, 69:9-21.
106. Petersen C.C. Genetic manipulation, whole cell recordings and functional imaging of the sensorimotor cortex of behaving mice. Acta Physiol. 2009, 195:91-99.
107. Pritchard J.W., Shulman R.G. NMR Spectroscopy of brain metabolism in vivo. Annu. Rev. Neurosci. 1986, 9:61-85.
108. Radda G.K. Control, bioenergetics, and adaptation in health and disease: noninvasive biochemistry from nuclear magnetic resonance. FASEB J. 1992, 6:3032-3038.
109. Renshaw P.F., Owen C.S., McLauglin A.C., Frey T.G., Leigh J.S. Ferromagnetic contrast agents: a new approach. Magn. Reson. Med. 1986, 3:217-225.
110. Roth B.J., Basser P.J. Mechanical model of neural tissue displacement during Lorentz effect imaging. Magn. Reson. Med. 2009, 61:59-64.
111. Schnall M.D., Bolinger L., Renshaw P.F., Haselgrove J.C., Subramanian V.H., Eleff S.M., Barlow C., Leigh J.S., Chance B. Multinuclear MR imaging: a technique for combined anatomic and physiologic studies. Radiology 1987, 162:863-866.
112. Shapiro E.M., Koretsky A.P. Convertible manganese contrast for molecular and cellular MRI. Magn. Reson. Med. 2008, 60:265-269.
113. Shapiro M.G., Atanasijevic T., Faas H., Westmeyer G.G., Jasanoff A. Dynamic imaging with MRI contrast agents: quantitative considerations. Magn Reson. Imaging 2006, 24:449-462.
114. Shapiro M.G., Westmeyer G.G., Romero P.A., Szablowski J.O., Kuster B., Shah A., Otey C.R., Langer R., Arnold F.H., Jasanoff A. Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine. Nat. Biotech. 2010, 28:264-270.
115. Silva A.C., Lee J.H., Wu C.W., Tucciarone J., Pelled G., Aoki I., Koretsky A.P. Detection of cortical laminar architecture using manganese enhanced MRI. J. Neurosci. Methods 2008, 167:246-257.
116. Smith G.A., Hesketh R.T., Metcalfe J.C., Feeney J., Morris P.G. Intracellular calcium measurements by 19F NMR of fluorine-labeled chelators. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:7178-7182.
117. So P.W., Hotee S., Herlithy A.H., Bell J.D. Generic method for imaging transgene expression. Magn. Reson. Med. 2005, 54:218-221.
118. Song A.W., Takahashi A.M. Lorentz effect imaging. Magn Reson Imaging 2001, 19:763-767.
119. Trowski R., Ren J., Kalman F.K., Sherry A.D. Selective sensing of zinc ions with a paracest contrast agent. Angew. Chem. Int. Ed. Engl. 2005, 44:6920-6923.
120. Tsien R.Y. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis and properties of prototype structures. Biochemistry 1980, 19:2396-2404.
121. Tucciarone J., Chuang K.H., Dodd S.J., Silva A., Pelled G., Koretsky A.P. Layer specific tracing of corticocortical and thalamocortical connectivity in the rodent using manganese enhanced MRI. NeuroImage 2009, 44:923-931.
122. Van de Velde G., Rangarajan J.R., Toelen J., Dresselaers T., Ibrahimi A., Krylychkina O., Vreys F., Van der Linden A., Maes F., Debyser Z., Himmelreich U., Baekelandt V. Evaluation of the specificity and sensitivity of ferritin as an MRI reporter gene in the mouse brain using lentiviral and adeno-associated viral vectors. Gene Ther. 2011, 18:594-605.
123. Viswanathan S., Kovacs Z., Green K.N., Ratnakar J., Sherry A.D. Alternatives to Gadolinium-based metal chelates for magnetic resonance imaging. Chem. Rev. 2010, 110:2960-3018.
124. Waggoner A.S. Dye indicators of membrane potential. Annu. Rev. Biophys. Bioeng. 1979, 8:47-68.
125. Walter G., Barton E.R., Sweeny H.L. Noninvasive measurement of gene expression in skeletal muscle. Proc. Natl. Acad. Sci USA 2000, 97:5151-5155.
126. Wang C., Gordon P.B., Hustvedt S.O., Grant D., Sterud A.T., Martinsen I., Ahlstrom H., Hemmingsson A. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol. 1997, 38(4 Pt 2):665-676.
127. Wang K.H., Majewska A., Schummers J., farley B., Hu C., Sur M., Tonnegawa S. In vivo two-photon imaging reveals a role of arc in enhancing orientation specificity in visual cortex. Cell 2006, 126:389-402.
128. Ward K.M., Aletras A.H., Balaban R.S. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J. Magn. Reson. 2000, 143:79-87.
129. Watanabe T., Radulovic J., Spiess J., Natt O., Boretius S., Frahm J., Michaelis T. In vivo 3D MRI staining of the mouse hippocampal system using intracerebral injection of MnCl2. NeuroImage 2001, 22:860-867.
130. Weissleder R., Simonova M., Bogdanova A., Bredow S., Enochs W.S., Bogdanov A. MR imaging and scintigraphy of gene expression through melanin induction. Radiology 1997, 204:425-429.
131. Yang C.T., Li Y., Liu S. Synthesis and structural characterization of complexed of a DO3A-conjugated triphenylphosphonium cation with diagnostically important metal ions. Inorg. Chem. 2007, 46:8988-8997.
132. Yang P.F., Chen D.Y., Hu J.W., Chen J.H., Yen C.T. Functional tracing of medial nociceptive pathways using activity-dependent manganese-enhanced MRI. Pain 2011, 152:194-203.
133. Yu X., Wadghiri Y.Z., Sanes D.H., Turnbull D.H. In vivo auditory mapping gin mice with Mn-enhanced MRI. Nat. Neurosci. 2005, 8:961-968.
134. Yu X., Sanes D.H., Aristizabal O., Wadghiri Y.Z., Turnbull D.H. Large scale reorganization of the tonotopic map in mouse auditory midbrain revealed by MRI. Proc. Natl. Acad. Sci. USA 2007, 104:12193-12198.
135. Zhang S., Winter P., Wu K., Sherry A.D. A novel europium(III)-based MRI contrast agent. J. Am. Chem. Soc. 2001, 123:1517-1518.
136. Zhang X.A., Lovejoy K.S., Jasanoff A., Lippard S.J. Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing. Proc. Natl. Acad. Sci. 2007, 104:10780-10785.
137. Zhang X., Bearer E.L., Boulat B., Hall F.S., Uhl G.R., Jacobs S.E. Altered neurocircuitry in the dopamine transporter knockout mouse brain. PLoS One 2010, 5:11506.
138. Ziv K., Meir G., Harmein A., Shimoni E., Klein E., Neeman M. Ferritin as a reporter gene for MRI: chronic liver over expression of H-ferritin during dietary iron supplementation and aging. NMR Biomed. 2010, 23:523-531.
139. Zurkiya O., Chan A.W., Hu X. MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn. Reson. Med. 2008, 59:1225-1231.